R-Tech Ueno Completes Registration For Phase III Japan Trials Of Retinitis Pigmentosa Drug
This article was originally published in PharmAsia News
Executive Summary
R-Tech Ueno completed the registration of symptoms in its Phase III trials with its unoprostone ophthalmic solution for the treatment of retinitis pigmentosa in Japan.